CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice
March 6th 2023
Drs Khushalani, Dietrich, Luke, and Patel discuss the nuances of defining resectability in cutaneous squamous cell carcinoma, the evolving treatment paradigm of resectable disease, and how to translate updated data with cemiplimab into clinical practice.